ALX Oncology Holdings Inc.

NASDAQ:ALXO

1.34 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -160.805-123.482-83.463-45.74-19.243-13.731
Depreciation & Amortization 0.8360.3420.0510.2020.4290.431
Deferred Income Tax -0.458001.27100
Stock Based Compensation 26.27323.83913.9145.4360.2970.269
Change In Working Capital 8.2979.85-4.0270.2474.257-0.159
Accounts Receivables 0000.5360.396-0.932
Inventory 000-0.536-0.3960
Accounts Payables 0.4584.5063.29-3.7442.976-0.269
Other Working Capital 7.8395.344-7.3173.9911.2810.11
Other Non Cash Items -4.5070.2285.4240.2950.0112.332
Operating Cash Flow -130.364-89.223-68.101-38.289-14.249-13.19
Investing Activities:
Investments In Property Plant And Equipment -1.274-1.427-4.923-0.031-0.353-0.653
Acquisitions Net 00.23400.64100
Purchases Of Investments -246.629-376.7890000
Sales Maturities Of Investments 292.56142.80000
Other Investing Activites 0.046-0.234-4.2570.64100
Investing Cash Flow 44.657-235.416-4.9230.61-0.353-0.653
Financing Activities:
Debt Repayment 000000
Common Stock Issued 59.6790.9032.753368.2560.010.007
Common Stock Repurchased 0.5230.3360.2020.0030-0.006
Dividends Paid 000-0.00300
Other Financing Activities 59.679-0.6552.753101.13115.3470
Financing Cash Flow 59.2919.862.472462.88115.3570.001
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -26.416-314.779-70.552425.2020.755-13.842
Cash At End Of Period 22.40648.888363.667434.2199.0178.262